Structural information about the HIV or SIV envelope glycoprotein will be important for design and development of vaccine immunogens. The overall goal of this component is to study the structure of the trimeric, """"""""pre-fusion"""""""" state of the HIV/SIV gp160 ectodomain (referred to as """"""""gp 140"""""""") and, in conjunction with the other components of the Project, to probe the immunological properties of gp140. The intial goal is to obtain by electron cryomicroscopy a moderate-resolution (12-18 A) image of trimeric SIV gpl40, chosen because of the greater stability of the trimer (with respect to HIV gp140). We will use single-particle analysis of individual gp140 trimers and of more symmetrical assemblies of trimers created by use of an ATCase fusion protein already successfully expressed. We will also attempt to make two-dimensional arrays on lipid substrates. We will determine the binding sites and orientations of neutralizing antibodies by """"""""decorating"""""""" gp140 trimers with Fabs and determining those structures by single-particle analysis, and we will determine the locations of variable loops through study of appropriate deletants. We will fit known substructures into the moderate resolution model, taking into account the positions of epitopes and variable loops, We will use the accumulated information to design a new generation of stablized, trimeric ectodomains in the prefusion conformation, for crystallization and structure determination by X-ray crystallography.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI043649-05
Application #
6569529
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2002-08-01
Project End
2007-07-31
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Tomaras, Georgia D; Montefiori, David C (2014) Spectrum of HIV antibodies in vaccine and disease. Curr Opin HIV AIDS 9:207-9
Hatfield, Stephen; Belikoff, Bryan; Lukashev, Dmitriy et al. (2009) The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells. J Leukoc Biol 86:545-8
Song, Likai; Sun, Zhen-Yu J; Coleman, Kate E et al. (2009) Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc Natl Acad Sci U S A 106:9057-62
Sun, Zhen-Yu J; Oh, Kyoung Joon; Kim, Mikyung et al. (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28:52-63
Kim, Mikyung; Qiao, Zhisong; Yu, Jessica et al. (2007) Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state. Vaccine 25:5102-14
Kim, Mikyung; Qiao, Zhi-Song; Montefiori, David C et al. (2005) Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res Hum Retroviruses 21:58-67
Reche, Pedro A; Zhang, Hong; Glutting, John-Paul et al. (2005) EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 21:2140-1
Qiao, Zhi-Song; Kim, Mikyung; Reinhold, Bruce et al. (2005) Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration. J Biol Chem 280:23138-46
Chen, Bing; Vogan, Erik M; Gong, Haiyun et al. (2005) Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. Structure 13:197-211
Chen, Bing; Cheng, Yifan; Calder, Lesley et al. (2004) A chimeric protein of simian immunodeficiency virus envelope glycoprotein gp140 and Escherichia coli aspartate transcarbamoylase. J Virol 78:4508-16

Showing the most recent 10 out of 15 publications